Posted in | News | Nanobusiness

Veeco Appoints New Executive Vice President and Chief Financial Officer

Veeco Instruments Inc. (Nasdaq: VECO), manufactures enabling solutions for customers in the HB-LED, solar, data storage, semiconductor, scientific research and industrial markets, today announced that David D. Glass, 50, will be joining the Company effective January 18, 2010 as Executive Vice President, Finance and Chief Financial Officer (CFO).

Mr. Glass will replace John F. Rein, Jr., 63, who announced his retirement from Veeco last year. Mr. Glass joins Veeco following a twenty-five year career with Rohm and Haas Company, a $10 billion global specialty materials company that was acquired in 2009 by The Dow Chemical Company.

Mr. Glass recently returned from Shanghai after serving there as both CFO of Rohm and Haas’ $2 billion Electronic Materials division and CFO of the Rohm and Haas Asia-Pacific region. From 2003-2007, Mr. Glass served as Rohm and Haas’ Corporate Controller, based in Philadelphia, PA, where he led a 350-person staff and was responsible for company-wide accounting, financial controls and SEC reporting. Previously, he was posted in China, initially as Finance Director of APAC and then as General Manager of Rohm and Haas’ Coatings business for Greater China, where he oversaw manufacturing, technical support, sales and marketing teams. Prior to that, he was based in Montgomeryville, PA as President of Toso-Haas Biotech, a stand-alone joint venture between Rohm and Haas and Tosoh of Japan. Mr. Glass’ prior roles included a five-year UK-based assignment, first as Finance Director for Europe, and then later as Director, European Emerging Markets Business Development. He has been involved in over a dozen M&A transactions for Rohm and Haas. Mr. Glass holds a Masters Degree in Finance, Economics and International Business from Northwestern University, a Bachelor of Arts Degree in Accounting from Lewis University, and passed the CPA exam in 1981.

John Peeler, Veeco’s Chief Executive Officer, commented, “Dave possesses the right combination of operational and financial skills to help me lead Veeco during this period of rapid business expansion. His over 20 years at a world-class corporation such as Rohm and Haas, in a diverse set of managerial, financial and operational roles make him uniquely suited to be our next CFO. I want to take this opportunity to thank Jack for his many contributions to Veeco, and to welcome Dave on board as the new leader of Veeco’s already strong global finance organization.”

“I am excited to join Veeco as the Company is poised to achieve new levels of growth, with significant opportunities around the world,” commented Mr. Glass. “I am impressed with Veeco’s deep technology and strong market leadership positions in each of its businesses. I look forward to partnering with John and the team to drive Veeco’s future success.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Veeco. (2019, February 14). Veeco Appoints New Executive Vice President and Chief Financial Officer. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=15328.

  • MLA

    Veeco. "Veeco Appoints New Executive Vice President and Chief Financial Officer". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=15328>.

  • Chicago

    Veeco. "Veeco Appoints New Executive Vice President and Chief Financial Officer". AZoNano. https://www.azonano.com/news.aspx?newsID=15328. (accessed November 21, 2024).

  • Harvard

    Veeco. 2019. Veeco Appoints New Executive Vice President and Chief Financial Officer. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=15328.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.